STPG2 and leiomyosarcoma: Another noteworthy event in the leiomyosarcoma case was the fusion between the PSIP1 gene, involved in the DNA-binding transcription factor and chromatin-binding activity, and the STPG2 gene, which was validated by Sanger sequencing (Figure 6).